| Value | ₹492.6 Cr |
|---|
NSE filing, NSE: RGL. Summary written from the filing by ALFA Finder's alert engine.
Renaissance Global Ltd: key numbers
- Share price
- ₹140.82
- Market cap
- ₹1,513 Cr
- Revenue (annual)
- ₹2,813 Cr
- Net profit (annual)
- ₹90.09 Cr
- P/E (TTM)
- 13.9×Sector 49.8×
- Promoter holding
- 61.93%-0.02% QoQ
- FII holding
- 3.96%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Renaissance Global Ltd
All →Renaissance Global Other Announcement
Renaissance Global Limited has appointed Cygnus Partners Private Limited as its Investor Relations Agency. This is a routine administrative appointment for advisory services.
Renaissance Global Employee Stock Options
Renaissance Global allotted 40,000 equity shares under the RGL ESOP 2021 scheme following the exercise of options by employees.
Renaissance Global Business Update
Renaissance Global Ltd has terminated its Investor Relations Agency Agreement with Merlin Capital Advisors by mutual consent, effective October 13, 2026.
Renaissance Global Other Announcement
Renaissance Global received a voluntary ESG rating of '65 Strong' from CRISIL ESG for FY 2025-26. The company was not engaged for the rating; it was assigned independently from public data.
Renaissance Global Promoter Reclassification
BSE and NSE rejected Renaissance Global Limited's application to reclassify Mr. Amit Shah from 'Promoter' to 'Public' category, citing non-compliance with regulatory control and shareholding conditions.
Renaissance Global Employee Stock Options
Renaissance Global Limited allotted 3,750 equity shares upon exercise of ESOPs. The exercise generated proceeds of ₹0.04 Crore for the company.
- Value
- ₹0.04 Cr
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.